Search results
Showing 46 to 60 of 282 results for covid-19
Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma (TA897)
Evidence-based recommendations on daratumumab (Darzalex) with bortezomib and dexamethasone for previously treated multiple myeloma in adults.
What is the clinical and cost effectiveness of budesonide for treating COVID-19 in the community in adults, young people and children?...
efficacy and safety of COVID-specific antiviral drugs in combination with other COVID-specific...
(VTE) prophylaxis for people who have been discharged after treatment for COVID-19? Any explanatory notes(if applicable) Suggested PICO...
Using NICE content for AI purposes. Includes complete content, adaptation, contextualisation, translation, selected extracts and the use of our COVID-19 content internationally.
This quality standard covers the initial assessment and management of suspected acute respiratory infection in over 16s, including acute respiratory infection virtual wards.
View quality statements for QS210Show all sections
Sections for QS210
- Quality statements
- Quality statement 1: Documented initial assessment
- Quality statement 2: Prescribing antimicrobials
- Quality statement 3: Antibiotic duration
- Quality statement 4: Information about acute respiratory infection virtual wards
- Quality statement 5: Multidisciplinary team
- Quality statement 6: Support to self-manage on a virtual ward
- Quality statement 7: Virtual ward discharge summaries
combination of casirivimab and imdevimab at doses other than 8 g for treating COVID-19? Any explanatory notes(if applicable) Suggested...
to specialist palliative care services improve outcomes for adults with COVID-19 thought to be approaching the end of their life? Any...
Recommendation ID NG191/12 Question In people with suspected COVID-19-associated pulmonary aspergillosis (CAPA), what are the most...
pathophysiological mechanism(s) underlie the most common presentations of post-COVID-19 syndrome? For example, generalised fatigue,...
awake body positioning in improving outcomes for people in hospital with COVID-19 who are not intubated and have higher oxygen needs?...
pharmacological venous thromboembolism (VTE) prophylaxis for people with COVID-19, with or without additional risk factors for VTE? Any...
Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards
result in stopping continuous positive airway pressure for people with COVID-19 and acute respiratory failure? Any explanatory notes(if...
FebriDx for C-reactive protein and myxovirus resistance protein A testing (MIB224)
NICE has developed a medtech innovation briefing (MIB) on FebriDx for C-reactive protein and myxovirus resistance protein A testing .